B of A Securities has maintained its rating for Teladoc Health (TDOC, Financial) at "Neutral", while lowering its price target. The new target price is now set at $7.00 USD, down from the previous target of $8.00 USD. This adjustment represents a 12.5% decrease in the price target.
The action was undertaken by analyst Allen Lutz, who issued the update on May 28, 2025. Despite the lowered price target, the neutral rating remains unchanged, indicating the analyst's steady view on Teladoc Health's current market performance.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 19 analysts, the average target price for Teladoc Health Inc (TDOC, Financial) is $8.92 with a high estimate of $12.00 and a low estimate of $7.00. The average target implies an upside of 27.72% from the current price of $6.99. More detailed estimate data can be found on the Teladoc Health Inc (TDOC) Forecast page.
Based on the consensus recommendation from 26 brokerage firms, Teladoc Health Inc's (TDOC, Financial) average brokerage recommendation is currently 2.8, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Teladoc Health Inc (TDOC, Financial) in one year is $18.64, suggesting a upside of 166.86% from the current price of $6.985. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Teladoc Health Inc (TDOC) Summary page.
